JSP 564 (Levothyroxine 137 mcg (0.137 mg))
Pill imprint JSP 564 has been identified as Levothyroxine sodium 137 mcg (0.137 mg).
Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 137 mcg (0.137 mg) is not a controlled substance under the Controlled Substance Act (CSA).
- JSP 564
- 137 mcg (0.137 mg)
- 7.00 mm
- Prescription only
- Drug Class:
- Thyroid drugs
- Pregnancy Category:
- A - Studies show no risk
- CSA Schedule:
- Not a controlled drug
- Lannett Company, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium starch glycolate type A potato
FD&C Blue No. 1
|NDC Code||Manufacturer / Repackager|
|21695-0755||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about levothyroxine
- Levothyroxine capsules
- Levothyroxine solution
- Levothyroxine (Advanced Reading)
- Levothyroxine Injection (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.